Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
608 in adult non-radiographic axial spondyloarthritis
CTR20260106Phase 3Active
- Sponsor
- 3S Guojian Pharmaceutical
- Start
- Feb 2026
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of 608 in axial spondyloarthritis (axSpA), sponsored by 3S Guojian Pharmaceutical. Started Feb 2026; status: active.
02
Drugs
608
03
Conditions
axial spondyloarthritis (axSpA)
Beyond the preview
Go deeper on CTR20260106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260106.